<DOC>
	<DOC>NCT01053312</DOC>
	<brief_summary>This study will determine the level of association between the quantitative estimates of brain uptake of [18F]flutemetamol and the quantitative immunohistochemical estimates of amyloid levels in biopsy samples previously obtained during shunt placement in patients who have normal pressure hydrocephalus (NPH).</brief_summary>
	<brief_title>PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus</brief_title>
	<detailed_description />
	<mesh_term>Hydrocephalus</mesh_term>
	<mesh_term>Hydrocephalus, Normal Pressure</mesh_term>
	<criteria>The subject is 50 years old or older. The subject has had a frontal lobe cortical biopsy adequate for the detection and quantitation of amyloid. Informed consent has been signed and dated by the subject/and/or subjects' legally acceptable representative, if applicable, in accordance with local regulations. The subject has a contraindication for MRI or PET. The subject has a known or suspected hypersensitivity/allergy to [18F]flutemetamol. The subject has participated in any clinical study using an investigational agent within 30 days of dosing.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Amyloid</keyword>
	<keyword>NPH Normal pressure hydrocephalus</keyword>
	<keyword>PET Positron Emission Tomography</keyword>
	<keyword>SUVR Standard uptake value ratios</keyword>
</DOC>